Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials

Archives of Internal Medicine

Volumn 170, Issue 3, 2010, Pages 240-250

  De Bruin, Marijn ^a,c   Viechtbauer, Wolfgang ^b   Schaalma, Herman P ^a   Kok, Gerjo ^a   Abraham, Charles ^d   Hospers, Harm J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR CHANGE; CLINICAL PRACTICE; CLINICAL TRIAL; DATA BASE; EFFECT SIZE; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MEDICAL RESEARCH; META ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 76249093081     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.536     Document Type: Review

References (75)

1. Gross R, Yip B, Lo Re V III, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194(8):1108-1114.
2. Knobel H, Alonso J, Casado JL, et al; GEEMA Study Group. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002;16(4):605-613.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
4. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant J. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112-1118.
5. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions; a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285-297.
6. Haddad M, Inch C, Glazier RH, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2000;(3):CD001442.
7. Rueda S, Park-Wyllie LY, Bayoumi AM, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006;3(3):CD001442.
8. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(S1)(suppl 1):S23-S35.
9. de Bruin M, Viechtbauer W, Hospers HJ, Schaalma HP, Kok G. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. Health Psychol. 2009;28(6):668-674.
10. Wagner GJ, Kanouse DE. Assessing usual care in clinical trials of adherence interventions for highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;33(2):276-277.
11. Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol. 2008;27(3):379-387.
12. Bartholomew LK, Parcel GS, Kok G, Gottlieb NH. Planning Health Promotion Programs: An Intervention Mapping Approach. 1st ed. San Francisco, CA: Jossey-Bass; 2006.
13. Bandura A. Self-efficacy: The Exercise of Control. New York, NY: W. H. Freeman; 1997.
14. Acarturk C, Cuijpers P, van Straten A, de Graaf R. Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med. 2009;39(2):241-254.
15. Prendergast ML, Podus D, Chang E, Urada D. The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies. Drug Alcohol Depend. 2002;67(1):53-72.
16. Berger S, Schad T, von Wyl V, et al. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS. 2008;22(6):767-775.
17. Jones DL, Ishii M, LaPerriere A, et al. Influencing medication adherence among women with AIDS. AIDS Care. 2003;15(4):463-474.
18. Mann T. Effects of future writing and optimism on health behaviors in HIV-infected women. Ann Behav Med. 2001;23(1):26-33.
19. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. www.cochrane-handbook.org. Accessed January 6, 2009.
20. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-395.
21. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151-1162.
22. Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20(9):1295-1302.
23. Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. J Assoc Nurses AIDS Care. 2002;13(6):57-69.
24. Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19(8):807-814.
25. van Servellen G, Nyamathi A, Carpio F, et al. Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish speaking Latinos.AIDSPatient Care STDS. 2005;19(11):745-759.
26. Brug J, Glanz K, Van Assema P, Kok G, van Breukelen G. The impact of computer-tailored feedback and iterative feedback on fat, fruit, and vegetable intake. Health Educ Behav. 1998;25(4):517-531.
27. Mullen PD, Green LW, Persinger GS. Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Prev Med. 1985;14(6):753-781.
28. Noar SM, Benac C, Harris M. Does tailoring matter? meta-analytic review of tailored print health behavior change interventions. Psychol Bull. 2007;133(4):673-693.
29. Petty R, Barden J, Wheeler S. The elaboration likelihood model of persuasion: health promotions that yield sustained behavioral change. In: DiClemente R, Crosby R, Kegler M, eds. Emerging Theories in Health Promotion Practice and Research. San Francisco, CA: Jossey-Bass; 2002:71-99.
30. Prochaska J, DiClemente C, Norcross J. In search of how people change: applications to addictive behaviors. In: Marlatt G, VandenBos G, eds. Addictive Behaviors: Readings on Etiology, Prevention, and Treatment. Washington, DC: American Psychological Association; 1997:671-696.
31. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(10):756-765.
32. Nellen JF, Wit FW, Wolf F, Jurriaans S, Lange JM, Prins JM. Virological and immunological response to HAART in indigenous and nonindigenous HIV-1 infected patients in the Netherlands. J Acquir Immune Defic Syndr. 2004;36:943-950.
33. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968-977.
34. Melbourne KM, Geletko S, Brown S, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read. 1999;9(5):329-338.
35. Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S103-S106.
36. Amico KR, Harman JJ, O'Grady MA. Attrition and related trends in scientific rigor: a score card for ART adherence intervention research and recommendations for future directions. Curr HIV/AIDS Rep. 2008;5(4):172-185.
37. van Houwelingen HC, Arends L, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589-624.
38. Willett J, Singer JD. Another cautionary note about R2: its use in weighted least-squares regression analysis. Am Stat. 1988;42(3):236-238.
39. Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIVinfected subjects with memory impairment. Clin Infect Dis. 2005;41(6):875-882.
40. Collier AC, Ribaudo H, Mukherjee A, Feinberg J, Fischl M, Chesney M; Adult AIDS Clinical Trials Group 746 Substudy Team. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005;192(8):1398-1406.
41. DiIorio C, McCarty F, Resnicow M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273-283.
42. DiIorio C, Resnicow K, McDonnell M, Soet J, McCarthy F, Yeager K. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14(2):52-62.
43. Golin CE, Earp J, Tien H, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42-51.
44. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;34(2):191-194.
45. Holzemer WL, Bakken S, Portillo CJ, et al. Testing a nurse-tailored HIV medication adherence intervention. Nurs Res. 2006;55(3):189-197.
46. Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Assoc Physicians AIDS Care. 2006;5(4):143-150.
47. Johnson MO, Charlebois E, Morin S, Remien R, Chesney M; National Institute of Mental Health Healthy Living Project Team. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The Healthy Living Project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574-580.
48. Jones DL, McPherson-Baker S, Lydston D, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women's Project. AIDS Behav. 2007;11(1):79-86.
49. Koenig LJ, Pals SL, Bush T, Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159-169.
50. Knobel H, Carmona A, Lopez JL, et al. Adherence to highly active antiretroviral treatment: impact of individualized assessment [in Spanish]. Efermedades Infecciocas Microbiologica y Clinica. 1999;17(2):78-81.
51. Mannheimer S, Morse EM, Andrews L, Child C, Schmetter B, Friedland G. Sustained benefit from a long-term antiretroviral adherence intervention results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(suppl 1):41-47.
52. Milam J, Richardson JL, McCutchan A, et al. Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. J Acquir Immune Defic Syndr. 2005;40(3):356-363.
53. Murphy DA, Marelich W, Rappaport N, Hoffman D, Farthing C. Results of an antiretroviral adherence intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). J Int Assoc Physicians AIDS Care (Chic Ill). 2007;6(2):113-124.
54. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4(2):121-131.
55. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in the treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005;27(2):199-209.
56. Rawlings MK, Thompson M, Farthing C, et al; NZTA4006 Helping to Enhance Adherence to Antiretroviral Therapy (HEART) Study Team. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/ abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34(2):174-183.
57. Reynolds N, Testa M, Su M, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008;47(1):62-68.
58. Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000;15(12):841-847.
59. Safren SA, Hendriksen E, Desousa N, Boswell S, Mayer K. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15(6):787-793.
60. Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488-495.
61. Smith SR, Rublein JC, Marcus C, Brock TP, Chesney MA. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns. 2003;50(2):187-199.
62. Tuldrà A, Wu AW. Interventions to improve adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S154-S157.
63. Weber R, Christen L, Christen S, et al; Swiss HIV Cohort Study. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther. 2004;9(1):85-95.
64. Wohl AR, Garland WH, Valencia R, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619-1627.
65. Fisher JD, Fisher W, Bryan A, Misovich S. Information-motivation- behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychol. 2002;21(2):177-186.
66. Rothstein H, Sutton A, Borenstein M. Publication Bias in Meta-analysis: Prevention, Assessment, and Adjustments. Chichester, England: Wiley; 2005.
67. Goldie SJ, Paltiel AD, Weinstein MC, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632-641.
68. Scalera A, Bayoumi AM, Oh P, Risebrough N, Shear N, Tseng AI. Clinical and economic implications of non-adherence to HAART in HIV infection. Dis Manag Health Outcomes. 2002;10(2):85-91.
69. Green LW, Kreuter MW. Health Promotion Planning: An Educational and Ecological Approach. 3rd ed. Mountain View, CA: Mayfield; 1999.
70. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363(9421):1589-1597.
71. Gras L, van Sighem A, Smit C, Zaheri S, Schuitemaker H, de Wolf H. Response to CART. Amsterdam, the Netherlands: HIV Monitoring Foundation; 2008.
72. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293- 299.
73. Boutron I, Moher D, Altman D, Schulz K, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295-309.
74. Davidson KW, Goldstein M, Kaplan RM, et al. Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med. 2003;26(3):161-171.
75. Schaalma H, Kok G. Decoding health education interventions: the times are a-changin'. Psychol Health. 2009;24(1):5-9.